Stocks and Investing Stocks and Investing
Mon, May 11, 2020

Raghuram Selvaraju Reiterated (SPRO) at Strong Buy with Increased Target to $28 on, May 11th, 2020


Published on 2024-10-27 06:06:16 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Spero Therapeutics, Inc." (SPRO) at Strong Buy with Increased Target from $25 to $28 on, May 11th, 2020.

Raghuram has made no other calls on SPRO in the last 4 months.



There is 1 other peer that has a rating on SPRO. Out of the 1 peers that are also analyzing SPRO, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $21 on, Tuesday, March 17th, 2020

Contributing Sources